Home › Diffuse Intrinsic Pontine Glioma › Florida › Miami
Diffuse Intrinsic Pontine Glioma clinical trials in Miami, FL
6 studies for Diffuse Intrinsic Pontine Glioma are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
RecruitingPhase 2
- Nicklaus Children's Hospital, Miami
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- University of Miami, Miami
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
RecruitingPhase 1/2
- Nicklaus Children's Hospital, Miami
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- University of Miami Hospital and Clinics, Miami
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
RecruitingPhase 2
- Nicklaus Children's Hospital, Miami
Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
RecruitingPhase 1/2Healthy volunteers welcome
- Jackson Memorial Hospital, Miami
Diffuse Intrinsic Pontine Glioma trials in other cities
- Washington, DC11 studies
- Philadelphia, PA10 studies
- Seattle, WA10 studies
- Columbus, OH10 studies
- Houston, TX10 studies
- Cincinnati, OH10 studies
- Durham, NC9 studies
- Boston, MA9 studies
- Chicago, IL9 studies
- Aurora, CO8 studies
- Ann Arbor, MI6 studies
- St. Louis, MO5 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer31 studies
- Prostate Cancer27 studies
- Obesity27 studies
- Acute Myeloid Leukemia24 studies
- Metastatic Cancer24 studies
- Ovarian Cancer23 studies
- Overweight23 studies
- Multiple Myeloma21 studies
- Ulcerative Colitis21 studies
- Alzheimer's Disease20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.